ASCO 2010: An immunotherapy approach to pancreatic cancer

Описание к видео ASCO 2010: An immunotherapy approach to pancreatic cancer

Dr Gregory Beatty - University of Pennsylvania, USA

Dr Beatty discusses his research into the use of the CD40 agonist monoclonal antibody CP-870,893 to treat pancreatic cancer. When used in conjunction with the gemcitabine, this antibody targets the immune system and causes it to seek out and fight the cancer, increasing progression free survival whilst reducing side effects and increasing patient quality of life.

Комментарии

Информация по комментариям в разработке